Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, has become increasingly recognized as a significant public health burden, especially hospital-acquired VTE in patients undergoing major surgery. VTE cancer surgery, DVT prophylaxis, VTE prophylaxis, DVT, PE, deep vein thrombosis, pulmonary embolism, mechanical thromboprophylaxis, intermittent pneumatic compression (IPC), graduated compression stockings (GCS)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: We included all VTE high-risk patients (Caprini risk score > 5) undergoing abdominopelvic surgery between 1 July 2018 and 31 December 2018 in the Departments of General surgery at Ramathibodi hospital, Mahidol University, Bangkok, Thailand. The age of the patients was over 18 years old.
Exclusion criteria
Exclusion criteria: The patients who took anticoagulants or history of DVT or peripheral arterial disease or glomerular filtration rate (GFR) less than 30 ml/min or history of allergic to anticoagulant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Venous thromboembolism 28 days after surgery Venous duplex ultrasound | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events 28 days after surgery Review chart and patients interview | — |
Countries
Thailand
Contacts
Ramathibodi